Sensei Biotherapeutics

(NASDAQ) SNSE

Current Price$23.34

Market Cap$589.56M

Since IPO (2021)-94%

5 Year-90%

1 Year+173%

1 Month+37%

Sensei Biotherapeutics Financials at a Glance

Market Cap

$589.56M

Revenue (TTM)

-$4.85M

Net Income (TTM)

-$184.46M

EPS (TTM)

-$142.73

P/E Ratio

-0.16

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$23.34

Volume

3,719

Open

$24.78

Price

$23.34

Volume

3,719

Open

$24.78

Previous Close

$23.34

Daily Range

$22.40 - $24.78

52-Week Range

$6.33 - $36.76

Estimated Earnings Date

Aug 4, 2026

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$23.34

Volume

3,719

Open

$24.78

Previous Close

$23.34

Daily Range

$22.40 - $24.78

52-Week Range

$6.33 - $36.76

Estimated Earnings Date

Aug 4, 2026

SNSE News

Sensei (SNSE) Q2 Loss Narrows 31%

Motley Fool Markets TeamAug 6, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sensei Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Christopher W. Gerry

Website

senseibio.com

Headquarters

Rockville, MD 02210, US

SNSE Financials

Key Financial Metrics (TTM)

Gross Margin

2740.82%

Operating Margin

3826.86%

Net Income Margin

3802.47%

Return on Equity

-283.67%

Return on Capital

-110.88%

Return on Assets

-89.81%

Earnings Yield

-6.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$589.56M

Shares Outstanding

25.78M

Volume

3.72K

Avg. Volume

55.50K

Financials (TTM)

Gross Profit

-$132.96M

Operating Income

-$185.64M

EBITDA

-$184.30M

Operating Cash Flow

-$24.09M

Capital Expenditure

-$22.00K

Free Cash Flow

-$24.11M

Cash & ST Invst.

$202.79M

Total Debt

$1.04M

Sensei Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$132.96M

N/A

Gross Margin

0.00%

N/A

Market Cap

$589.56M

N/A

Market Cap/Employee

$42.11M

N/A

Employees

N/A

Net Income

-$170.24M

-2380.1%

EBITDA

-$170.21M

-2396.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$202.79M

+490.7%

Total Debt

$1.04M

-67.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.00K

-99.9%

Short Term Debt

$1.04M

-51.7%

Return on Assets

-89.81%

N/A

Return on Invested Capital

-97.10%

N/A

Free Cash Flow

-$10.74M

-51.4%

Operating Cash Flow

-$10.73M

-51.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CINGCingulate Inc.

CINGCingulate Inc.$5.32+7.26%

MRKRMarker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.$1.46+11.03%

COCPCocrystal Pharma, Inc.

COCPCocrystal Pharma, Inc.$1.03+0.98%

CLRBCellectar Biosciences, Inc.

CLRBCellectar Biosciences, Inc.$2.60+3.17%

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$3.91-8.66%

TRAWTraws Pharma, Inc.

TRAWTraws Pharma, Inc.$0.82-0.76%

IMNNImunon, Inc.

IMNNImunon, Inc.$1.80+0.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CMCSAComcast

CMCSAComcast$24.22+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92+0.00%

NOKNokia

NOKNokia$13.03+0.00%

TAT&T

TAT&T$21.82-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.64+0.17%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.19+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.16-0.08%

Questions About SNSE

What is the current price of Sensei Biotherapeutics?

Sensei Biotherapeutics is trading at $23.34 per share.

What is the 52-week range for Sensei Biotherapeutics?

Over the past 52 weeks, Sensei Biotherapeutics has traded between $6.33 and $36.76.

How much debt does Sensei Biotherapeutics have?

As of the most recent reporting period, Sensei Biotherapeutics reported total debt of $1.04M.

How much cash does Sensei Biotherapeutics have on hand?

Sensei Biotherapeutics reported $152.33M in cash and cash equivalents in its most recent financial results.

What is Sensei Biotherapeutics’s dividend yield?

Sensei Biotherapeutics does not currently have a dividend yield.

Sensei Biotherapeutics

Sensei Biotherapeutics Financials at a Glance

SNSE News

Sensei (SNSE) Q2 Loss Narrows 31%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sensei Biotherapeutics

SNSE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sensei Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SNSE

What is the current price of Sensei Biotherapeutics?

What is the 52-week range for Sensei Biotherapeutics?

How much debt does Sensei Biotherapeutics have?

How much cash does Sensei Biotherapeutics have on hand?

What is Sensei Biotherapeutics’s dividend yield?

Premium Investing Services